text_1: Nanoparticles can be targeted against specific cell types by incorporating aptamers into lipid nanoparticles.
text_2: These results indicate that osteoblast-specific aptamer-functionalized LNPs could act as a new RNAi-based bone anabolic strategy, advancing the targeted delivery selectivity of osteogenic siRNAs from the tissue level to the cellular level.